January 31, 2026 · Form 4 insider transaction
Boyer David W. sold 1,189 shares of Neurocrine Biosciences, Inc. at $136.06 per share, a transaction worth $161.8K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 3 days after the transaction.
Shares withheld by Neurocrine Biosciences, Inc. (the "Company" or "Issuer") to satisfy tax withholding requirements on vesting of restricted stock units ("RSUs"). No shares were sold.